Abstract:Acrylamide classified as a probable carcinogen to humans is a high production volume chemical in industrial applications released to aquatic and environmental ecosystems, and also widely found in the thermal processing of starch-rich foods. To gain insight into the urinary metabolomics that may induce physiological responses stimulated by acrylamide, rats were orally administered with a single dose of 13C3-acrylamide (10 mg/kg bw) in the treatment group and urine samples were continuously collected every 2 h during the first 18 h and every 3 h during the period from 18 h to 36 h. A reliable nontargeted screening method for the analysis of urinary metabolomics in rats was developed using ultra-high performance liquid chromatography coupled to quadrupole-Orbitrap high-resolution mass spectrometry. All metabolites in urine of rats receiving isotope-labeled acrylamide were screened by validated orthogonal partial least squares-discriminant analyses compared to the animals in the control group, while exposure biomarkers were further confirmed according to the characteristic fragmentation rules and time-dependent profiles. Here we identified 2 new specific exposure biomarkers, named N-acetyl-S-(2-carbamoyl-2-hydroxyethyl)-L-cysteine-sulfoxide and N-acetyl-S-(2-carboxyl)-L-cysteine, compared to 4 currently acknowledged mercapturic acid adducts of acrylamide. In addition, our findings on analysis of acrylamide metabolic pathway and identification of exposure biomarkers confirmed that acrylamide could significantly affect energy metabolism and amino acid metabolism by the Kyoto Encyclopedia of Genes and Genomes pathway analysis for key metabolites. Homocysteine thiolactone and hypoxanthine may be potential biomarkers for the cardiotoxicity, while methionine sulfoxide, hippuric acid and melatonin may be specifically related to the neurotoxicity. Thus, the current study provided new evidence on the identification of emerging exposure biomarkers and specific signature metabolites related to the toxicity of acrylamide, and shed light on how acrylamide affected energy and amino acid metabolism by further mapping urinary metabolic fingerprints.

Reconstructing hepatic metabolic profile and glutathione-mediated metabolic fate of acrylamide

Metabolism of Acrylamide: Interindividual and Interspecies Differences As Well As the Application As Biomarkers

Toxicokinetics and Internal Exposure of Acrylamide: New Insight into Comprehensively Profiling Mercapturic Acid Metabolites As Short-Term Biomarkers in Rats and Chinese Adolescents.

Acrylamide-Induced Hepatotoxicity Through Oxidative Stress: Mechanisms and Interventions

The Construction and Application of Physiologically Based Toxicokinetic Models for Acrylamide, Glycidamide and Their Biomarkers in Rats and Humans.

Characterization of primary glutathione conjugates with acrylamide and glycidamide: Toxicokinetic studies in Sprague Dawley rats treated with acrylamide

Comprehensive Profiling of Mercapturic Acid Metabolites from Dietary Acrylamide As Short-Term Exposure Biomarkers for Evaluation of Toxicokinetics in Rats and Daily Internal Exposure in Humans Using Isotope Dilution Ultra-High Performance Liquid Chromatography Tandem Mass Spectrometry.

Unraveling the Serum Metabolomic Profile of Acrylamide-Induced Cardiovascular Toxicity

Phosphatidylcholine Protects Against the Hepatotoxicity of Acrylamide Via Maintaining Metabolic Homeostasis of Glutathione and Glycerophospholipid

Biomarker Analysis of Hemoglobin Adducts of Acrylamide and Glycidamide Enantiomers for Mid-Term Internal Exposure Assessment by Isotope Dilution Ultra-High Performance Liquid Chromatography Tandem Mass Spectrometry.

Acrylamide induced glucose metabolism disorder in rats involves gut microbiota dysbiosis and changed bile acids metabolism

Advanced Research on Metabolic Mechanism and Toxicity Protection of Acrylamide:in Vivo

Nontargeted metabolomics-based mapping urinary metabolic fingerprints after exposure to acrylamide

Toxicogenomic Evaluation of Liver Responses Induced by Acrylamide and Glycidamide in Male Mouse Liver.

Characterization of Acrylamide-Induced Oxidative Stress and Cardiovascular Toxicity in Zebrafish Embryos.

Genotoxicity of Acrylamide in Human Hepatoma G2 (hepg2) Cells

Metabolic profiling using combined GC-MS and LC-MS provides a systems understanding of aristolochic acid-induced nephrotoxicity in rat.

Role of glutathione on acrylamide inhibition: Transformation products and mechanism

Lactobacillus reuteri ameliorates chronic acrylamide-induced glucose metabolism disorder via bile acids-TGR5-GLP-1 axis and modulates intestinal oxidative stress in mice

Rapid Simultaneous Determination of Cascade Metabolites of Acrylamide in Urine for Toxicokinetics Profiles and Short-Term Dietary Internal Exposure.

Proteomic Profiling of Primary Astrocytes and Co-Cultured Astrocytes/microglia Exposed to Acrylamide.